Veracyte Inc.

NASDAQ: VCYT · Real-Time Price · USD
30.31
0.27 (0.90%)
At close: Aug 15, 2025, 12:49 PM

Veracyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
445.76M 361.05M 296.54M 219.51M
Cost of Revenue
156.22M 112.9M 101.58M 74.4M
Gross Profit
289.55M 248.15M 194.95M 145.11M
Operating Income
16.14M -85.8M -41.08M -81.9M
Interest Income
11.15M 7.34M 1.97M 135K
Pretax Income
25.74M -76.61M -36.43M -81.65M
Net Income
24.14M -74.4M -36.56M -75.56M
Selling & General & Admin
206.04M 184.23M 174.08M 181.19M
Research & Development
69.29M 57.3M 40.6M 29.84M
Other Expenses
18.22M 92.41M 21.35M 15.98M
Operating Expenses
293.56M 333.94M 236.03M 227.02M
Interest Expense
2K 15K 198K 241K
Selling & Marketing Expenses
27.77M 26.6M 97.56M 79.84M
Cost & Expenses
429.62M 446.85M 337.62M 301.42M
Income Tax Expense
1.61M -2.21M 133K -6.09M
Shares Outstanding (Basic)
76.48M 72.64M 71.55M 67.89M
Shares Outstanding (Diluted)
78.16M 72.64M 71.55M 67.89M
EPS (Basic)
0.32 -1.02 -0.51 -1.11
EPS (Diluted)
0.31 -1.02 -0.51 -1.11
EBITDA
49.2M -49.41M -6.98M -60.18M
EBIT
25.75M -76.6M -36.23M -81.41M
Depreciation & Amortization
23.46M 27.19M 29.25M 21.23M